Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 88391

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 02, 2021
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Macleods Pharma Usa Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15

D-0787-2021
Recall number
D-0787-2021
Initiated
August 02, 2021
Classification
Class II
Status
Terminated
Recalling firm
Macleods Pharma Usa Inc
Quantity
444,000 tablets / 888 unit packs of 500 count

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
foreign matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of foreign matter

Code information

Lot # BCA82021A, Exp 06/2023

Distribution pattern

Product was distributed nationwide.